BlackRock, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for INOZYME PHARMA INC Common Stock (INZY)

Filing Manager: BlackRock, Inc.
Reporting Manager: BlackRock, Inc.
Security: INOZYME PHARMA INC Common Stock
Symbol: INZY
Shares outstanding: 64,967,756 shares
Disclosed Ownership: 2,663,678 shares
Ownership: 4.1%
Form type: SCHEDULE 13G/A
Filing time: 17 Jul 2025, 19:54:39 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BlackRock, Inc.	4.1%	2,663,678	2,663,678	0	Spencer Fleming	Managing Director